ESCMID takes great pride in our efforts to support and encourage women working in CM/ID to develop their leadership skills. This course is designed specifically for women in healthcare and organised by the female board members of the ESCMID Foundation. Participants can expect to engage in hands-on sessions, strategic simulations, and co-creation exercises designed to build resilience, decision-making skills, and elevate their impact as scientific leaders.

There are five attendance grants available to ESCMID Young Scientist members to attend the course. Apply today and register for an immersive training experience tailored to the unique challenges and strengths of women in leadership.

Attendance grant application closes 27 August 2025.

Registration deadline is 31 August 2025.

Science and Research

Applications for individual research grants for 2026 are still open under the theme for this year, bacterial infections and diseases. These grants are a fantastic opportunity for early-career researchers to secure their first grants and make their first steps into the academic field of research. The deadline to apply is 10 September 2025.

Starting tomorrow, applications for the Study Group Collaboration Grant open. This larger-scale grant is designed to support innovative translational research projects organised by an experienced PI with the support of at least three ESCMID Study Groups. Applications are open from 20 August until 29 October 2025.

Discover all of our upcoming webinars organised with other societies and with our ESCMID Study Groups. This comprehensive database is updated regularly so be sure to check back often to see what’s coming up and mark it in your calendar.

Education

This course is targeted for microbiologists and infectious disease specialists who seek to update their knowledge on the theoretical and practical aspects of current and advanced diagnosis and management of endocarditis and endovascular infections. The aim is to enhance participants’ understanding of diagnosis, treatment, infection control, improve practices, and prepare for the future.

In high-resistance endemic settings, difficult-to-treat infections are not just clinical challenges - they are urgent public health threats. This online course is designed specifically to empower professionals with the knowledge and practical tools to develop and lead antimicrobial stewardship programmes tailored to their local realities. Through this interactive course, participants will gain essential insights and strategies to combat antimicrobial resistance effectively, optimise patient care, and safeguard antibiotic efficacy for the future.

This course is part of the ESCMID AMS Certificate Programme and has a few spots available for extra participants.

Congress and Events

There's only one month left until IMMEM XIV kicks off! In scientific collaboration with ESGEM, ESCMID is excited to welcome the attendees to Porto, where together we will dive into topics such as how genomics inform resistance profiling to pathogen surveillance in a One Health framework. You can see the full programme live on our website - and be sure to secure your spot in this mainstay ESCMID conference! 

Late-breaking abstract submission for the 6th Vaccines Conference is open only for a little while longer. Be sure to send in your abstracts that highlight innovative approaches, emerging technologies, and challenges in vaccine deployment to be presented at this important event.

The deadline to submit is 29 August 2025. Learn more on our website and submit your research today!

Guidelines and Journals

Following in the steps of CMI and the journal’s fellowship programme, CMI Communications has opened a call for fellows. Now, both journals have open calls for fellows. Read more about the programmes on their respective websites:

Deadline 01 September

Deadline 15 September

Measles cases continue to rise across 10 countries, a 34-fold increase compared to 2024, mostly among the unvaccinated (71%). Canada, Mexico, and the USA are most affected. PAHO/WHO urges countries to strengthen vaccination campaigns, surveillance, and response capacity to prevent further spread. Chikungunya transmission is intensifying across continents. ECDC reports 59 new locally acquired cases in France and Italy. Brazil has seen almost 90k confirmed cases and several Indian Ocean countries are affected, prompting a CDC Level 2 travel notice. An outbreak of listeriosis in France and four other European countries has caused two deaths since June. Almost 13k confirmed Oropouche virus cases across 11 countries have been reported this year. Brazil remains the epicentre, followed by Panama and Peru. The cholera outbreak in Sudan continues to escalate with almost 100k suspected cases and ~2.5k deaths reported. This humanitarian crisis is aggravated by conflict, displacement, and limited access to healthcare.

Screening and Targeted Prophylaxis for Clostridioides difficile Infection: STOP-CDI

Antenatal corticosteroid treatment and infectious diseases in children and adolescents aged 5-16 years